Shopping Cart
- Remove All
- Your shopping cart is currently empty
GSK2646264 (Compound 44) is a highly effective and specific inhibitor of spleen tyrosine kinase (SYK) with a pIC50 of 7.1. It also inhibits multiple kinases, including LCK (pIC50 5.4), LRRK2 (pIC50 5.4), GSK3β (pIC50 5.3), JAK2 (pIC50 5), VEGFR2 (pIC50 4.5), Aurora B (pIC50 <4.6), and Aurora A (pIC50 <4.3). Notably, GSK2646264 demonstrates skin penetrability, reaching both the epidermis and dermis [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,110 | 8-10 weeks | |
50 mg | $3,360 | 8-10 weeks |
Description | GSK2646264 (Compound 44) is a highly effective and specific inhibitor of spleen tyrosine kinase (SYK) with a pIC50 of 7.1. It also inhibits multiple kinases, including LCK (pIC50 5.4), LRRK2 (pIC50 5.4), GSK3β (pIC50 5.3), JAK2 (pIC50 5), VEGFR2 (pIC50 4.5), Aurora B (pIC50 <4.6), and Aurora A (pIC50 <4.3). Notably, GSK2646264 demonstrates skin penetrability, reaching both the epidermis and dermis [1]. |
Targets&IC50 | Aurora A:<4.3 (pIC50), Aurora B:<4.6 (pIC50), VEGFR2:4.5 (pIC50), GSK-3β:5.3 (pIC50), LRRK2:5.4 (pIC50), Syk:7.1 (pIC50), LCK:5.4 (pIC50), JAK2:5 (pIC50) |
Molecular Weight | 374.48 |
Formula | C24H26N2O2 |
Cas No. | 1398695-47-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.